Carla Sevin, MD
NPI 1366599151 · Pulmonary Disease Physician · Nashville, TN
Enrolled with Medicare as Practitioner - Pulmonary Disease · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1366599151
- Entity type
- Individual
- Primary specialty
- Pulmonary Disease PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Female
- Sole proprietor
- No
- License
- MD0000043484 (TN)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
19 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
490 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 77 | $88 |
| Critical Care, First 30-74 Minutes99291 | 67 | $205 |
| Test to Examine How Well the Lungs Exchange Gases94729 | 55 | $8 |
| Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 35 Minutes99232 | 54 | $68 |
| Test to Measure Expiratory Airflow and Volume94010 | 48 | $8 |
| Test to Measure Expiratory Airflow and Volume94010 | 33 | $7 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 14 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Montelukast Sodium | 84 | 21 |
| Fluticasone Propionate | 49 | 13 |
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 47 | 19 |
| Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta | 40 | — |
| Dupilumabbrand: Dupixent Pen | 25 | — |
| Budesonide/Formoterol Fumaratebrand: Budesonide-Formoterol Fumarate | 19 | — |
Practice location
Mailing address
Registry dates
- Enumerated
- 2007-01-04
- Last updated
- 2022-03-23
- Certified
- 2022-03-23
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.